NCT06243120View on ClinicalTrials.gov

Intravenous Lidocaine for Treating Intrathecal Fentanyl Induced Pruritus

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

September 1, 2024

Study Completion Date

October 1, 2024

Conditions
Pruritus Caused by Drug
Interventions
DRUG

Lidocaine IV

The study group will receive lidocaine (2%) 1mg/ kg iv diluted by normal saline to a volume of 100 ml. The VAS will be assessed every 10 minutes for 60minutes after the treatment. A regression of more than 4 points of VAS score is considered a success and if less than 4 points , it will be considered as a failure.

Trial Locations (1)

3567

Ain Shams University Hospital, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT06243120 - Intravenous Lidocaine for Treating Intrathecal Fentanyl Induced Pruritus | Biotech Hunter | Biotech Hunter